Predictive Value of Inflammatory Biomarkers and FEV1 for COPD

CompletedOBSERVATIONAL
Enrollment

10,385

Participants

Timeline

Start Date

March 3, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

October 9, 2021

Conditions
COPDFEV1
Interventions
OTHER

No intervention

This is a multi-center,observational, prospective, cohort study. A total of 10,000 subjects aged 40~75 without history of lung disease will be recruited and followed for 3 years. So there is no intervention in this study.

Trial Locations (10)

100034

Peking University First Hospital, Beijing

Unknown

The First Hospital of Qinhuangdao, Qinhuangdao

The Second Hospital of Hebei Medical University, Shijiazhuang

Henan Provincial People's Hospital, Zhengzhou

The Affiliated Hospital of Inner Mongolia Medical University, Hohhot

The Second Hospital of Jilin University, Changchun

Shandong Provincial Hospital Affiliated to Shandong University, Jinan

The First Affiliated Hospital of Shanxi Medical University, Taiyuan

The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an

Tianjin Medical University General Hospital, Tianjin

All Listed Sponsors
collaborator

The Second Hospital of Hebei Medical University

OTHER

collaborator

Henan Provincial People's Hospital

OTHER

collaborator

Second Hospital of Jilin University

OTHER

collaborator

First Affiliated Hospital Xi'an Jiaotong University

OTHER

collaborator

Shandong Provincial Hospital

OTHER_GOV

collaborator

Shanxi Dayi Hospital

OTHER

collaborator

Tianjin Medical University General Hospital

OTHER

collaborator

The Affiliated Hospital of Inner Mongolia Medical University

OTHER

collaborator

The First Hospital of Qinhuangdao

OTHER_GOV

lead

Peking University First Hospital

OTHER

NCT03532893 - Predictive Value of Inflammatory Biomarkers and FEV1 for COPD | Biotech Hunter | Biotech Hunter